ライフサイエンスコーパス: intensive care

1 birth weight (725 g) neonate EGA 25 weeks in intensive care.

2 rs) and was assessed for the first 7 days of intensive care.

3 ent from the immediacy often associated with intensive care.

4 t to decide on continuation or withdrawal of intensive care.

5 e and antihistamine treatment and, possibly, intensive care.

6 The first patient died despite maximal intensive care.

7 of depression and anxiety is elevated after intensive care.

8 logy (1.3%; 95% CI, 0.0%-3.9%) and pediatric intensive care (0%) units had the least effect.

9 ospital (median, 15 vs 25 days; P < .01) and intensive care (10 vs 17 days; P = .04) than those treat

10 decedents were overall more likely to die in intensive care (15.6% vs 10.0%; difference, 5.6%; 95% CI

11 associated with greater mean (+/-SD) use of intensive care (5.3+/-7.1 vs. 4.9+/-7.0 days, P=0.04) an

12 capnic acidosis during the first 24 hours of intensive care admission is more strongly associated wit

13 outcomes in the unmatched cohort, including intensive care admission, rehospitalizations, and self-r

14 iatrogenic injury that occurs subsequent to intensive care admission.

15 f mechanical ventilation following unplanned intensive care admission.

16 % CI 0.28 to 0.90; p=0.0210), fewer neonatal intensive care admissions lasting more than 24 h (0.48;

17 occurrence of chronic wounds, which require intensive care and constant monitoring.

18 Intensive care and hospital stays were significantly mor

19 ARTICIPANTS AND Twenty-two nurses working in intensive care and medical-surgical units within a large

20 METHODS AND TBI patients requiring neuro-intensive care and not included in the initial creation

21 tage renal disease, and cirrhosis), need for intensive care, and mortality.

22 care service contact such as inpatient stay, intensive care, and psychosocial assessment.

23 lity as requests for resuscitation, neonatal intensive care, and surgical intervention are becoming m

24 ompt antitoxin administration and meticulous intensive care are essential for optimal outcome.

25 es the clinical course of patients requiring intensive care as a result of their primary medical or s

26 ata prospectively collected by the Pediatric Intensive Care Audit Network over 8 years (2007-2014).

27 iously healthy children requiring support in intensive care because of a severe illness caused by a r

28 ountries at risk of ZIKV epidemics, adequate intensive care bed capacity is required for management o

29 Increasingly, intensive care bed expansion in the United States is occ

30 Overall, the majority of intensive care bed growth occurred in teaching hospitals

31 sures time series analysis of hospital-level intensive care bed supply using data from Centers for Me

32 examined the relationship between increasing intensive care beds and these characteristics, controlli

33 ht to better characterize national growth in intensive care beds by identifying hospital-level factor

34 Although the number of intensive care beds in the United States is increasing,

35 nited States acute care hospitals with adult intensive care beds over the years 1996-2011.

36 actors associated with increasing numbers of intensive care beds over time.

37 We correctly predicted that 8 intensive-care beds and 7 ventilators would be sufficien

38 rt comprised patients from neurosurgical and intensive care centers in Edinburgh and Newcastle (n = 7

39 Cardiothoracic adult intensive care department.

40 ion, urban hospitals providing more resource-intensive care did not achieve better outcomes.

41 ty to other professionals (eg, physicians in intensive care, emergency medicine, neurology, neurosurg

42 2014 that participated in the Dutch National Intensive Care Evaluation registry.

43 n and discharge data from the Dutch National Intensive Care Evaluation registry.

44 Relative risk of dying in intensive care for recent immigrants compared with long-

45 l patients were given appropriate supportive intensive care for what was initially suspected to be se

46 European Society for Paediatric and Neonatal Intensive Care; four experts of the European Society for

47 al management of patients, particularly with intensive care, has also contributed to improving outcom

48 in intrauterine interventions and perinatal intensive care have resulted in increasing numbers of BH

49 The Effective Perinatal Intensive Care in Europe (EPICE) study, a population-bas

50 ients with anti-NMDAR encephalitis requiring intensive care is good, especially when immunotherapy is

51 mission (RR = 3.4, 99% CI: 3.2, 3.6), longer intensive care length of stay (incidence rate ratio = 2.

52 ht to characterize the timing, severity, and intensive care management of cytokine release syndrome a

53 instem dysfunction; it was severe, requiring intensive care management.

54 Need for intensive care, mechanical ventilation, and invasive pro

55 re significantly younger and had more severe intensive care medical conditions (hemodynamic, biologic

56 al Care Medicine and the European Society of Intensive Care Medicine.

57 Care Medicine and/or the European Society of Intensive Care Medicine.

58 Intensive Care National Audit & Research Centre Case Mix

59 ion before ICU admission (odds ratio, 1.90), Intensive Care National Audit & Research Centre Physiolo

60 ion before ICU admission (odds ratio, 1.63), Intensive Care National Audit & Research Centre Physiolo

61 ger hospital size, teaching status, and high intensive care occupancy were associated with subsequent

62 number of beds, teaching status, ownership, intensive care occupancy, and urbanicity for each hospit

63 fic health condition or those recruited from intensive care or high dependency hospital units were ex

64 f stay (LOS), and 5 indicators of morbidity: intensive care or surgery admissions, number of diagnost

65 ve patients with sepsis, 11 severity-matched intensive care patients, and 67 healthy donors was prosp

66 Sixty-three ICUs in the Swedish Intensive Care Registry.

67 esenting symptoms or signs, hospitalization, intensive care, respiratory support, or laboratory resul

68 scribed associated clinical outbreaks in the intensive care setting, affecting the critically ill and

69 of patient- and family-centered care in the intensive care setting.

70 and surgery services in hospital in the non-intensive-care setting.

71 of data from the Australian and New Zealand Intensive Care Society Adult Patient Database and a nest

72 xtracted from the Australian and New Zealand Intensive Care Society Centre for Outcome and Resource E

73 xtracted from the Australian and New Zealand Intensive Care Society Centre for Outcome and Resource E

74 identified in the Australian and New Zealand Intensive Care Society Centre for Outcome and Resource E

75 set was associated with shorter hospital and intensive care stays.

76 nce LOS nor the need for hospital admission, intensive care, surgery, or diagnostic tests.

77 its first description 50 years ago, no other intensive care syndrome has been as extensively studied

78 hallenges of studying ARDS, as well as other intensive care syndromes, and propose solutions to addre

79 Intensive care teams are not meeting their ethical respo

80 s in theatre, within 4 hours of returning to intensive care, they were reassessed using transthoracic

81 Intensive Care to facilitate Organ Donation (ICOD) may h

82 istics of patients with cellulitis requiring intensive care treatment are poorly defined.

83 antibiotic selection that was greater in the intensive care unit (77.97% [CI 72.0-83.1] vs 54.73% [CI

84 Early reports suggest the number of cardiac intensive care unit (CICU) patients with primary noncard

85 fty years after the inception of the cardiac intensive care unit (CICU), noncardiovascular illnesses

86 d to questioning of the beneficial effect of intensive care unit (ICU) admission and to a variable IC

87 g chemotherapy in the final 14 days of life, intensive care unit (ICU) admission in the final 30 days

88 Death, intensive care unit (ICU) admission, and hospital and IC

89 tly increased early postoperative mortality, intensive care unit (ICU) admission, and ICU/hospital le

90 workers or the environment to patients in an intensive care unit (ICU) and a high-dependency unit (HD

91 rly populations; studies based solely in the intensive care unit (ICU) and non-English-language artic

92 RATIONALE: The austere setting of the intensive care unit (ICU) can suppress expressions of sp

93 eveloping a secondary infection while in the intensive care unit (ICU) display sustained inflammatory

94 y failure episode requiring admission to the intensive care unit (ICU) has been reported in the liter

95 placebo-controlled trial in a general adult intensive care unit (ICU) in Watford General Hospital (W

96 oints measured in terms of duration, such as intensive care unit (ICU) length of stay (LOS), are wide

97 There are limited data on intensive care unit (ICU) management of these patients.

98 ity of ventilatory support, NIV failure, and intensive care unit (ICU) mortality.

99 S. aureus infection in the intensive care unit (ICU) most commonly manifests as sep

100 Delirium is a common disorder in Intensive Care Unit (ICU) patients and is associated wit

101 Intensive care unit (ICU) patients are particularly at r

102 n from a prospective study of critically ill intensive care unit (ICU) patients meeting two of four S

103 RATIONALE: Intensive care unit (ICU) patients who receive mechanica

104 reactivations of herpesviruses may occur in intensive care unit (ICU) patients, even in those withou

105 httime intensivist staffing with outcomes of intensive care unit (ICU) patients.

106 To determine the discriminative accuracy of intensive care unit (ICU) physicians and nurses in predi

107 cell transplantation (SCT) recipients to the intensive care unit (ICU) remains controversial, especia

108 9 hours; P = 0.002; I(2) = 53%), and reduced intensive care unit (ICU) stay (WMD = -0.23 days; P = 0.

109 Intensive care unit (ICU) utilization may have important

110 ukemia (AML) commonly require support in the intensive care unit (ICU), but risk factors for admissio

111 r up to 48 hours or until discharge from the intensive care unit (ICU), in addition to standard care.

112 In the intensive care unit (ICU), orotracheal intubation can be

113 RATIONALE: Intensive care unit (ICU)- and mechanical ventilation (M

114 The primary outcome was the number of intensive care unit (ICU)-free days to day 28.

115 transplant recipients from the same thoracic intensive care unit (ICU).

116 e to identify high-risk patients outside the intensive care unit (ICU).

117 equently seen dermatological diseases in the intensive care unit (ICU).

118 fection causes high mortality in patients in intensive care unit (ICU).

119 [3.1%] in the PD group) or length of cardiac intensive care unit (median, 7 [IQR, 6-12] vs 9 [IQR, 5-

120 under intubation/ventilation outside of the intensive care unit (n = 59), or with the patient intuba

121 the patient intubated/ventilated within the intensive care unit (n = 93).Consent to ICOD was obtaine

122 primary outcomes were prematurity, neonatal intensive care unit (NICU) admission, congenital malform

123 inal tracts of infants and from the neonatal intensive care unit (NICU) room environment.

124 We analyzed the relation between neonatal intensive care unit (NICU) strategies concerning the rat

125 found that more than 5 days admitted to the intensive care unit (odds ratio [OR], 4.11; 95% CI, 1.59

126 the causes of potentially avoidable surgical intensive care unit (SICU) admissions and disposition de

127 tiation of CRRT among patients in a surgical intensive care unit (SICU).

128 CAP outcomes (hospital length of stay [LOS], intensive care unit [ICU] admission, and invasive mechan

129 9.5 g per deciliter in the operating room or intensive care unit [ICU] or was <8.5 g per deciliter in

130 cesarean delivery, breast-feeding, neonatal intensive care unit [NICU] admission, and absence of pet

131 serin may provide the first ever therapy for intensive care unit acquired weakness in patients.

132 Weakness induced by critical illness (intensive care unit acquired weakness) is a major cause

133 To develop therapy for intensive care unit acquired weakness, it was necessary

134 ower motor neurons as a novel contributor to intensive care unit acquired weakness.

135 visit; and more than one hospitalization or intensive care unit admission < 30 days from death.

136 supplemental oxygen (P = .001), and require intensive care unit admission (P = .04); however, mechan

137 drome (RR = 6.5, 99% CI: 5.9, 7.1), neonatal intensive care unit admission (RR = 3.4, 99% CI: 3.2, 3.

138 ormation and assessments during the neonatal intensive care unit admission and longitudinal follow-up

139 nificantly lower risk of hospitalization and intensive care unit admission and shorter hospital stays

140 less likely to receive chemotherapy or have intensive care unit admission at the end of life, and we

141 ulting in a lower risk of hospitalization or intensive care unit admission compared with infants born

142 r Hospital Acquired Pressure Injuries during Intensive Care Unit admission than the control group (5

143 lism, hysterectomy), complications requiring intensive care unit admission, and maternal death.

144 disease, defined as mechanical ventilation, intensive care unit admission, or death.

145 Among acutely ill adult patients requiring Intensive Care Unit admission, the provision of optimal

146 rioration and respiratory failure, requiring intensive care unit admission.

147 d more applicable when considering mortality/intensive care unit admission.

148 and respiratory support during the neonatal intensive care unit admission.

149 d that subgroup membership is dynamic during intensive care unit admission.

150 ays (median, 24 days); 14% of cases required intensive care unit admission; 25% reported mechanical v

151 The HSHs were observed to have fewer intensive care unit admissions (1007 [2.6%] vs 1711 [5.0

152 ncy department visits, hospitalizations, and intensive care unit admissions decreased by 6.0%, 7.9%,

153 ncy department visits, hospitalizations, and intensive care unit admissions).

154 There was no significant difference in Intensive Care Unit admissions, 30 and 90-day mortality,

155 ergency department visits, hospitalizations, intensive care unit admissions, and chemotherapy in the

156 ed serious morbidity, in-hospital mortality, intensive care unit admissions, and cost.

157 2014, we surveyed all Thai hospitals with an intensive care unit and >/=250 beds.

158 ith various stages of ROP: 3 in the neonatal intensive care unit and 1 in the operating room.

159 rst quantitative data on turn quality in the Intensive Care Unit and highlight the need to reinforce

160 Intensive care unit and hospital discharge rates were 66

161 ductions in procedural inotrope requirement, intensive care unit and hospital length of stay (6.0 ver

162 and 30-day death/stroke, procedural success, intensive care unit and hospital length-of-stay, and rat

163 er among 4 neonates with ROP in the neonatal intensive care unit and in the operating room.

164 bilization of patients in the cardiothoracic intensive care unit and its effect on length of stay has

165 to first physical therapy evaluation in the intensive care unit and the hospital, and mean days of p

166 0-bed, multidisciplinary, tertiary pediatric intensive care unit between January 1, 2009 and August 1

167 's being discharged alive from the pediatric intensive care unit by a given day, under a range of sta

168 s (mean [SD] cost, MP $3530 [MP $2410]), and intensive care unit care (mean [SD] cost, MP $7770 [MP $

169 to receive aggressive care and to die in an intensive care unit compared with other residents.

170 Intensive care unit cost per bloodstream infection accou

171 consciousness and cortical responses in the intensive care unit could alter time-sensitive decisions

172 evaluation and treatment in a cardiothoracic intensive care unit could influence length of stay.

173 d discriminative power of our models with an Intensive Care Unit database (MIMIC-III) and demonstrate

174 ake to morbidity through our practice in the intensive care unit each day.

175 ctively enrolled 16 patients admitted to the intensive care unit for acute severe traumatic brain inj

176 mechanical ventilation, and admission to the intensive care unit for patients admitted to hospital fo

177 ng 974 adults admitted to a tertiary medical intensive care unit from February 3, 2015 to May 31, 201

178 particularly those requiring admission to an intensive care unit involving respiratory failure, intub

179 lty in older trauma patients admitted to the intensive care unit is often not feasible using traditio

180 er, the PDA stent group had a lower adjusted intensive care unit length of stay (5.3 days [95% CI, 4.

181 After adjustment for age, intensive care unit level of care, receipt of nephrotoxi

182 (15.40 versus 7.90 days; P = 0.027), and the intensive care unit LOS (5.55 versus 1.19 days; P = 0.03

183 derive a risk score predicting the need for intensive care unit observation in children with mTBI an

184 Blunt trauma patients admitted to the trauma intensive care unit of a level I trauma center were enro

185 patients 65 years and older admitted to the intensive care unit of a single level I trauma center be

186 view was conducted of adults admitted to the intensive care unit of an American College of Surgeons-v

187 36-bed, combined medical/surgical pediatric intensive care unit of an urban, academic, tertiary care

188 abies with type 1 zone 1 ROP at the Neonatal Intensive Care Unit of the Catholic University, Rome, fr

189 ed miR-542-3p/5p may cause muscle atrophy in intensive care unit patients through the promotion of mi

190 ow/neg) monocytic (M)-MDSCs were expanded in intensive care unit patients with and without sepsis and

191 In a prospective cohort study of intensive care unit patients with respiratory failure an

192 Despite extensive antibiotic treatment of intensive care unit patients, limited data are available

193 ssociated with high mortality, especially in intensive care unit patients.

194 These professionals are generally intensive care unit physicians with an enhanced focus an

195 death, the occurrence of adverse events, and intensive care unit resource use.

196 receiving VPT based on severity of illness, intensive care unit status, duration of combination ther

197 The median length of intensive care unit stay (151 vs 117 hours; P < .001), b

198 n time on mechanical ventilation (P = 0.59), intensive care unit stay (P = 0.74), highest primary gra

199 Median intensive care unit stay was 7 days (interquartile range

200 shorter duration of mechanical ventilation, intensive care unit stay, and inotrope use; and fewer el

201 Duration of ventilation, intensive care unit stay, and mortality (6, 17, and 29%

202 load, duration of mechanical ventilation and intensive care unit stay, electrolyte abnormalities and

203 rt-term (duration of mechanical ventilation, intensive care unit stay, hospital stay, and highest pri

204 atrial fibrillation, bleeding, and length of intensive care unit stay.

205 d increased nosocomial infections, prolonged intensive care unit stays, and poor functional status at

206 es, indicated by longer overall hospital and intensive care unit stays.

207 previously demonstrated in numerous surgical intensive care unit studies was not observed, which unde

208 ical therapy evaluation and treatment in the intensive care unit using a retrospective chart review.

209 Admission to the intensive care unit was required for 9 patients positive

210 Mortality and care in the intensive care unit were not associated with positive FU

211 ain injury (TBI) is currently managed in the intensive care unit with a combined medical-surgical app

212 lysed 170 patients consecutively admitted to intensive care unit with diagnosis of culture negative n

213 All patients admitted to the pediatric intensive care unit with length of stay of 4 hours or mo

214 tinely placed extraventricular drain, in the intensive care unit with stable, non-traumatic intracere

215 Except for one patient who died in the intensive care unit, all patients with cognitive motor d

216 The adjusted mean number of hospital, intensive care unit, and emergency room admissions decre

217 f TBI could change current management in the intensive care unit, enabling targeted interventions tha

218 re likely to experience the MI-EOL care (eg, intensive care unit, mechanical ventilation, odds ratios

219 discussions regarding extended stays in the intensive care unit, prolonged ventilator management, an

220 ampsia, gestational age at delivery, days in intensive care unit, sex, age, and body surface area at

221 th chronic obstructive pulmonary disease and intensive care unit-acquired weakness (ICUAW).

222 al hematoma are key risk factors for needing intensive care unit-level care in children with mTBI and

223 jor cause of infection-related deaths in the intensive care unit.

224 is a reality of the clinical context of the intensive care unit.

225 3 levels within 24 hours of admission to the intensive care unit.

226 Brigham and Women's Hospital Medical Intensive Care Unit.

227 these techniques have not been tested in the intensive care unit.

228 amples collected from trauma patients at the intensive care unit.

229 the operating room, emergency department, or intensive care unit.

230 ients and families at the end-of-life in the intensive care unit.

231 ll-cause mortality and length of stay in the intensive care unit.

232 s than or equal to 300 mm Hg admitted to the intensive care unit.

233 tional age (SGA) baby; need for the neonatal intensive care unit; doubling of serum creatinine or inc

234 n criteria were admission to a participating intensive-care unit (including transfers) within the enr

235 anical ventilation and length of stay in the intensive-care unit were significantly shorter in patien

236 units (15.5%, 95% CI 11.6-20.3) and neonatal intensive care units (10.7%, 9.0-12.7).

237 ence of infections was highest in paediatric intensive care units (15.5%, 95% CI 11.6-20.3) and neona

238 uma and respiratory failure at 14 university intensive care units (ICUs) across the United States.

239 spective, randomized, open-label trial in 16 intensive care units (ICUs) and 6 countries.

240 , and mortality of sepsis in adult Brazilian intensive care units (ICUs) and association of ICU organ

241 randomized clinical superiority trial in 10 intensive care units (ICUs) at 10 university hospitals i

242 diagnosis in 182 Australian and New Zealand intensive care units (ICUs) from 2000 through 2015.

243 lticenter, randomized trial conducted at 120 intensive care units (ICUs) from 9 countries from Novemb

244 secutive patients admitted for sepsis to two intensive care units (ICUs) in the Netherlands between J

245 nt gram-negative bacteria (MDR-GNB) in adult intensive care units (ICUs).

246 and most spend their first weeks in neonatal intensive care units (NICUs) [1].

247 cases were reviewed from 2 academic neonatal intensive care units (NICUs) from 2004 to 2015.

248 To determine the proportion of neonatal intensive care units (NICUs) in 2014 that achieved rates

249 ant PDA was conducted at 3 tertiary neonatal intensive care units and affiliated follow-up programs.

250 ation is still a frightening complication in intensive care units and has a high mortality.

251 enic disorders in the neonatal and pediatric intensive care units and its use has a notable effect on

252 y of 350 critically ill patients admitted to intensive care units at an academic medical center to in

253 Medical and Surgical Intensive Care Units at Massachusetts General Hospital (

254 The setting was neonatal intensive care units at The Children's Hospital of Phila

255 ly to receive chemotherapy or be admitted to intensive care units at the end of life.

256 of 441 patients with ARDS admitted to three intensive care units at the University Medical Centre id

257 cutive adult patients admitted to one of two Intensive Care Units between September 2015 to January 2

258 cted influenza infection across 38 pediatric intensive care units during November 2008 to April 2016.

259 -center randomized controlled trial at three intensive care units from a French university hospital b

260 onates admitted to 24 participating neonatal intensive care units from four countries (Australia, Can

261 January 2006 and December 2013 from neonatal intensive care units in 25 US children's hospitals inclu

262 Two Intensive Care Units in a large Academic Medical Center

263 rt study in pediatric, cardiac, and neonatal intensive care units in eight hospitals, carried out fro

264 linked with structural data from 66 neonatal intensive care units in Germany.

265 l infarction (59% STEMI) admitted to cardiac intensive care units in metropolitan France.

266 atients with sepsis admitted to two tertiary intensive care units in the Netherlands between January

267 ents with severe sepsis or septic shock in 2 intensive care units in the Netherlands from 2011 to 201

268 sed, placebo-controlled phase 2 trial in two intensive care units in the UK, involving patients fulfi

269 A major obstacle to therapy in intensive care units is sepsis caused by severe infectio

270 ital cardiac arrest who were hospitalized in intensive care units or general inpatient units were stu

271 2010 and 2011 who were admitted to neonatal intensive care units participating in the Canadian Neona

272 udy involving patients admitted to pediatric intensive care units to define the incremental risk of d

273 ive Pediatric Critical Care Research Network intensive care units with chest compressions for >/=1 mi

274 tioner for surrogates of patients in medical intensive care units with chronic critical illness (i.e.

275 RATIONALE: Patients admitted to intensive care units with sepsis are prone to developing

276 umannii is a pathogen of major importance in intensive care units worldwide, with the potential to ca

277 anesthesia is widely used in surgery and in intensive care units, and recent evidence indicates that

278 shock), which are leading causes of death in intensive care units, are still poorly understood.

279 tient wards including three male psychiatric intensive care units, one female acute ward and one male

280 ients receiving mechanical ventilation in 36 intensive care units, with daily collection of ventilati

281 ial performed at 33 US and Canadian neonatal intensive care units.

282 % of patients with sepsis hospitalized in US intensive care units.

283 ered as one of the most critical problems in intensive care units.

284 k place in Geriatric, Emergency and Surgical intensive care units.

285 ritically ill patients in adult and neonatal intensive care units.

286 between 2008 and 2014 in 21 French neonatal intensive care units.

287 cause of morbidity and mortality in neonatal intensive care units.

288 rospective cohort study at tertiary neonatal intensive care units.

289 ions to support surrogate decision-makers in intensive care units.

290 anagement of staphylococcal BSIs in neonatal intensive care units; and (5) defining the impact of VRE

291 winter, 2014, in a convenience sample of 459 intensive-care units in 50 countries across six continen

292 with the highest, were associated both with intensive care use (adjusted odds ratio [aOR], 1.97; P =

293 profile was associated with a higher risk of intensive care use (OR, 3.20; 95%CI, 1.18-8.68; P=.02) a

294 ota profiles with regard to the risk of both intensive care use (Pinteraction =.02) and hospital leng

295 Severity of bronchiolitis was defined by intensive care use and hospital length of stay.

296 and depression during the 3 years following intensive care was 18.0% (95% CI, 17.0-19.0%) for statin

297 traumatic brain injury patients admitted to intensive care who had suffered a primary, closed trauma

298 In adult patients admitted to intensive care who required acute volume resuscitation,

299 e interviewed to discuss organ donation once intensive care with a therapeutic purpose was deemed fut

300 ood leukocytes of adult patients admitted to intensive care with sepsis due to fecal peritonitis (n =